Prestige Consumer Healthcare Inc. (PBH) Stock Analysis
A live, multi-source view of Prestige Consumer Healthcare Inc. (PBH): real-time price, technical indicators, Wall Street analyst consensus, recent news sentiment and social buzz — aggregated into one place so you can size up the stock at a glance.
About Prestige Consumer Healthcare Inc.
Prestige Consumer Healthcare Inc., together with its subsidiaries, develops, manufactures, markets, distributes, and sells over the counter (OTC) health and personal care products in North America, Australia, and internationally. It operates in two segments, North American OTC Healthcare and International OTC Healthcare. The company offers analgesic powders under the BC and Goody's brand; various diaper rash treatments and skin protectants for babies under the Boudreaux's Butt Paste brand name; sprays and lozenges to relieve sore throats and mouth pain under the Chloraseptic brand; eye care products that provide relief from redness and itchiness under the Clear Eyes brand name; at-home removal of common and plantar warts under the Compound W brand; and ear wax removal products under the Debrox brand name.
Sector: Healthcare · Industry: Drug Manufacturers - Specialty & Generic · United States · 890 employees · prestigebrands.com
Key statistics · as of 2026-09-05
As of 2026-09-05, Prestige Consumer Healthcare Inc. (PBH) had a market capitalization of $2.48B, a trailing P/E of 14.7 (forward 10.3) and a beta of 0.33; the shares traded in a 52-week range of $42.62 – $71.07 (-20.1% over the year).
- Market cap
- $2.48B
- Enterprise value
- $4.45B
- Trailing P/E
- 14.7
- Forward P/E
- 10.3
- PEG ratio
- 1.61
- Price / book
- 1.29
- EPS (trailing)
- $3.55
- EPS (forward)
- $5.08
- Payout ratio
- 0.0%
- Ex-dividend date
- 2013-12-27
- 52-week range
- $42.62 – $71.07
- 52-week change
- -20.1%
- Beta
- 0.33
- Average volume
- 584,091
- Shares outstanding
- 47.4M
- Short % of float
- 10.88%
- Profit margin
- 15.6%
Fundamental figures are recorded once every few days, dated above; they are not live and can differ from the interactive tiles.
Last universe scan · 2026-09-11
In RapidTradeView’s 2026-09-11 scan of the US universe, Prestige Consumer Healthcare Inc. (PBH) last closed at $47.34 (the last completed close before that scan).
Technicals at the scan: RSI 35 (neutral territory), price -7.5% versus its 20-day average, 20-day versus 50-day average spread +0.9%, MACD histogram -0.52.
Sentiment inputs: analyst consensus score 71/100.
Next scheduled company event: in 55 days from the scan date.
Scan values are recorded once per trading day and are not live quotes; the interactive tiles above update in real time.
Smart Money · last 90 days
RapidTradeView has recorded no Congress or insider filing for PBH in the last 90 days. Coverage of House, Senate and SEC Form 4 filings began in July 2026, and insider sells are tracked for universe tickers only, so this is our record, not a guarantee that nothing was filed. Who is trading what
RapidTradeView pick record
PBH has not appeared in the daily picks yet. Full scoreboard
What this page covers
RapidTradeView pulls Prestige Consumer Healthcare Inc. (PBH) data from multiple independent sources and combines it into a single dashboard. Below the summary you’ll find live, interactive tiles for each of the following:
- Price & chart — real-time quote with pre/post-market moves and a line or candlestick chart.
- Technical indicators — RSI, MACD, moving averages, Bollinger Bands, volume and support/resistance, distilled into one overall signal.
- Analyst consensus — the buy/hold/sell breakdown and price targets published by Wall Street analysts.
- News sentiment — recent headlines, each scored for tone so the prevailing narrative is obvious.
- Earnings — current EPS, year-over-year change and the next scheduled earnings date.
- Social buzz — Reddit mention volume and StockTwits sentiment for the retail-trader angle.
How to read the signals
No single indicator tells the whole story. A bullish technical reading paired with a cautious analyst consensus, or strong social buzz against weak earnings, is exactly the kind of tension this view is built to surface. RapidTradeView’s signals are generated by deterministic, statistical models — they describe what the data is doing, they are not personalised recommendations to buy or sell PBH.
Disclaimer: RapidTradeView is an educational sentiment-aggregation tool, not a licensed financial adviser, broker, or dealer. Nothing here is financial, investment, tax, or legal advice. Markets are risky and you can lose money. Always do your own research and consult a qualified professional before making any investment decision.